• Products
  • Adacel
    • ADACEL® for Maternal Immunization: Protecting Infants from Pertussis
    • ADACEL® Tdap Vaccination in Pregnancy: Protecting Infants from Whooping Cough
    • Pregnancy Vaccination Guide: Protecting Mother and Baby from Whooping Cough
    • Protect Your Baby: Whooping Cough Vaccination During Pregnancy | Circle of Protection
    • Adacel® TDaP Vaccine: Boosting Immunity Against Tetanus, Diphtheria & Pertussis
    • Continue the Circle of Protection: Childhood Vaccination Boosters for Diphtheria, Tetanus, and Whooping Cough
    • Adacel PI
  • Epilim®
  • Aldurazyme®
  • Alfuwin®
  • Apidra®
  • Aryco®
  • Auberif™
  • Avaxim 160
  • Beyfortus®
    • RSV
    • MOA
    • Clinical Data
    • Safety
    • Administration
    • PI
  • Cerezyme®
  • Clexane®
  • Cordarone®
  • Dupixent
  • Dormonoct®
  • Elaprase®
  • Epilim®
  • Epilizine®
  • Fabrazyme®
  • Flagyl®
  • Hexaxim®
    • Hexaxim®
    • Hexaxim 10-year anniversary video
    • Hexaxim® Immunogenicity and Safety Profile in South Africa
  • Lantus®
  • Lasix®
  • Lemtrada®
    • Lemtrada
      • Dosing Guide
  • Menactra
  • Myozyme®
  • Optisulin®
  • Rilutek®
  • Soliqua
    • T2DM with SOLIQUA®
    • Soliqua PI
    • Soliqua Insulin Glargine
    • SOLIQUA Soli-ID Mary Post-BI
    • Soliqua Basal vs FRC VOD - Vivian Foncesca
    • Soliqua Post OAD VOD
  • Toujeo
    • TOUJEO Clinical Justification - upgrade from U-100 to GLA-300
    • Adults, adolescents and children from the age of 6 years with Type 1 or Type 2 Diabetes Mellitus requiring basal insulin
    • Toujeo PI
    • Toujeo Insulin Glargine
    • The Insulin Confidence Code Episodes
      • The Insulin Confidence Code: Episode 1: Type 2 Diabetes: Epidemiology & Diagnosis
      • The Insulin Confidence Code: Episode 2: Identifying the Right Patient - Clinical & Practical Cues
      • The Insulin Confidence Code: Episode 3: Why the Right insulin matters - comparing basal options
      • The Insulin Confidence Code: Episode 4: Navigating Insulin Therapy in Type 2 Diabetes
      • The Insulin Confidence Code: Episode 5: Insulin Types & Characteristics
      • The Insulin Confidence Code: Episode 6: Navigating Diabetes Treatment Challenges
      • The Insulin Confidence Code: Episode 7: Managing Diabetes in Special Populations
      • The Insulin Confidence Code: Episode 8: HIV & Diabetes and Patient Care Strategies
    • Start Module
      • START Module 3
      • START Module 2
      • START Module 1
    • Toujeo Post-GLP1 RAs
  • Typhim®
  • Tetraxim®
  • Thyrogen®
  • VaxigripTetra
    • VaxigripTetra
  • Verorab®
  • Clopiwin®
  • CoIrbewin®
  • Ivedal®
  • Irbewin®
  • Teicowin®
  • Thymoglobuline®
  • Stamaril®
  • Stilnox®
  • Solian Tablets®
  • Storwin®
  • Sabril®
  • Renvela®
• Events
  • Atopic Dermatitis
  • Diabetes
• Newsletters
• Privacy Policy
• Legal Notice
• Cookie policy
• Sitemap
• Articles
• Resource listing 2
• Search
• Login
• My Account
  • Manage Personal Information
  • Manage Preferences
  • Manage Subscriptions
  • Manage Password
  • Unsubscribe
• Incomplete Profile Notice
• Incomplete Profile
• Consent Acknowledge
• Bestell
• Science
  • Cutting Edge Science
  • Asthma
  • Atopic Dermatitis
  • Diabetes
    • 2023
    • 2025
    • 2024 GP Care Annual Forum VODs
  • Neurology
  • Rare Diseases
    • How to Diagnose Gaucher Disease
    • How to Diagnose Fabry Disease
    • How to Diagnose Pompe Disease
    • How to Diagnose MPS I & II Disease
    • Meet Sanofi Medical
    • Request Diagnostic Test
  • Thrombosis
    • 2022
    • 2022
    • Padua Prediction score Risk Assessment Model
    • RCOG Score Tool
    • Caprini Risk Assessment Tool
    • Khorana Risk Score
  • Vaccines
    • Meningitis
      • 2023
      • 2023
      • 2025
    • Pertussis
    • Influenza
    • Hepatitis A
    • Rabies
    • Newsletters
    • RSV
      • 2025
      • VOICES OF ALL INFANTS
• Registration
• Patient Support
  • Asthma
  • Atopic Dermatitis
  • Multiple Sclerosis
    • Risk Management Programme
      • Aubagio
      • Auberif
  • Rare Diseases